BMX controls 3βHSD1 and sex steroid biosynthesis in cancer von Li, Xiuxiu, Berk, Michael, Goins, Christopher, Alyamani, Mohammad, Chung, Yoon-Mi, Wang, Chenyao, Patel, Monaben, Rathi, Nityam, Zhu, Ziqi, Willard, Belinda, Stauffer, Shaun, Klein, Eric, Sharifi, Nima

Volltext

Predicting GFR after radical nephrectomy: the importance of split renal function von Rathi, Nityam, Palacios, Diego A., Abramczyk, Emily, Tanaka, Hajime, Ye, Yunlin, Li, Jianbo, Yasuda, Yosuke, Abouassaly, Robert, Eltemamy, Mohamed, Wee, Alvin, Weight, Christopher, Campbell, Steven C.

Volltext

Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy von Rathi, Nityam, Attawettayanon, Worapat, Yasuda, Yosuke, Lewis, Kieran, Roversi, Gustavo, Shah, Snehi, Wood, Andrew, Munoz-Lopez, Carlos, Palacios, Diego A., Li, Jianbo, Abdallah, Nour, Schober, Jared P., Strother, Marshall, Kutikov, Alexander, Uzzo, Robert, Weight, Christopher J., Eltemamy, Mohamed, Krishnamurthi, Venkatesh, Abouassaly, Robert, Campbell, Steven C.

Volltext

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro von Campbell, Steven C., Ornstein, Moshe C., Rathi, Nityam

Volltext

Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Rena... von Gan, Chun Loo, Dudani, Shaan, Wells, J. Connor, Donskov, Frede, Pal, Sumanta K., Dizman, Nazli, Rathi, Nityam, Beuselinck, Benoit, Yan, Flora, Lalani, Aly‐Khan A., Hansen, Aaron, Szabados, Bernadett, Velasco, Guillermo, Tran, Ben, Lee, Jae Lyun, Vaishampayan, Ulka N., Bjarnason, Georg A., Subasri, Mathushan, Choueiri, Toni K., Heng, Daniel Y. C.

Volltext

Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy von Rathi, Nityam, Yasuda, Yosuke, Palacios, Diego Aguilar, Attawettayanon, Worapat, Li, Jianbo, Bhindi, Bimal, Thompson, R. Houston, Liss, Michael A., Derweesh, Ithaar H., Weight, Christopher J., Eltemamy, Mohammed, Abouassaly, Robert, Campbell, Steven C.

Volltext

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consorti... von Donskov, Frede, Xie, Wanling, Overby, Anders, Wells, J. Connor, Fraccon, Anna P., Sacco, Cosimo S., Porta, Camillo, Stukalin, Igor, Lee, Jae-Lyun, Koutsoukos, Konstantinos, Yuasa, Takeshi, Davis, Ian D., Pezaro, Carmel, Kanesvaran, Ravindran, Bjarnason, Georg A., Sim, Hao-Wen, Rathi, Nityam, Kollmannsberger, Christian K., Canil, Christina M., Choueiri, Toni K., Heng, Daniel Y.C.

Volltext

Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer von Gurram, Sandeep, Rathi, Nityam

Volltext

Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary Kidney von Attawettayanon, Worapat, Yasuda, Yosuke, Zhang, JJ H., Kazama, Akira, Rathi, Nityam, Munoz-Lopez, Carlos, Lewis, Kieran, Shah, Snehi, Li, Jianbo, Emrich Accioly, João Pedro, Campbell, Rebecca A., Shah, Shetal, Wood, Andrew, Kaouk, Jihad, Haber, Georges-Pascal, Eltemamy, Mohamad, Krishnamurthi, Venkatesh, Abouassaly, Robert, Weight, Christopher, Derweesh, Ithaar, Campbell, Steven C.

Volltext

ASO Author Reflections: Predicting New Baseline Renal Function After Partial Nephrectomy: The Importance of Accuracy, Conceptual Simplicity, and Clinical Practicality von Rathi, Nityam, Campbell, Steven C.

Volltext

Predicting Renal Function following Nephroureterectomy can Impact Timing of Systemic Chemotherapy von Munoz-Lopez, Carlos, Rathi, Nityam, Campbell, Steven C.

Volltext

Every decade counts: a narrative review of functional recovery after partial nephrectomy von Campbell, Steven C., Campbell, Jack A., Munoz‐Lopez, Carlos, Rathi, Nityam, Yasuda, Yosuke, Attawettayanon, Worapat

Volltext

Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors von Campbell, Steven C., Attawettayanon, Worapat, Munoz-Lopez, Carlos, Rathi, Nityam

Volltext

Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer von Rathi, Nityam, McFarland, Taylor Ryan, Nussenzveig, Roberto, Agarwal, Neeraj, Swami, Umang

Volltext

A Bosniak IV Cystic Renal Mass with Mixed Epithelial and Stromal Tumor Features von Rathi, Nityam, Shah, Shetal N, Przybycin, Christopher G

Volltext

Phase II study of axitinib prior to partial nephrectomy to preserve renal function: An interim analysis of the PADRES clinical trial von Hakimi, Kevin, Campbell, Steven, Nguyen, Mimi, Rathi, Nityam, Wang, Luke, Rini, Brian I., Ornstein, Moshe Chaim, McKay, Rana R., Derweesh, Ithaar H

Volltext

BMX controls 3[beta]HSD1 and sex steroid biosynthesis in cancer von Li, Xiuxiu, Berk, Michael, Goins, Christopher, Alyamani, Mohammad, Chung, Yoon-Mi, Wang, Chenyao, Patel, Monaben, Rathi, Nityam, Zhu, Ziqi, Willard, Belinda, Stauffer, Shaun, Klein, Eric, Sharifi, Nima

Volltext

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer von Sena, Laura A., Fountain, Julia, Isaacsson Velho, Pedro, Lim, Su Jin, Wang, Hao, Nizialek, Emily, Rathi, Nityam, Nussenzveig, Roberto, Maughan, Benjamin L., Velez, Miguel Gonzalez, Ashkar, Ryan, Larson, Amanda C., Pritchard, Colin C., Adra, Nabil, Bryce, Alan H., Agarwal, Neeraj, Pardoll, Drew M., Eshleman, James R., Lotan, Tamara L., Antonarakis, Emmanuel S.

Volltext

Accuracy of fully automated, AI-generated models compared with validated clinical model to predict post-operative glomerular filtration rate after renal surgery von Abdallah, Nour, Benidir, Tarik, Heller, Nicholas, Wood, Andrew, Isensee, Fabian, Tejpaul, Resha, Suk-ouichai, Chalairat, Rathi, Nityam, Aguilar Palacios, Diego, You, Alex, Remer, Erick M., Kaouk, Jihad, Haywood, Samuel, Krishnamurthi, Venkatesh, Campbell, Steven, Papanikolopoulos, Nikolaos, Weight, Christopher J.

Volltext

BMX inhibition and HSD3B1 -driven resistance in prostate cancer in the Maverick trial von Sharifi, Nima, McKay, Rana R., Vinson, Jake, Royal, Mike A., Lang, Joshua Michael, Klein, Eric A., Li, Xiuxiu, Berk, Michael, Goins, Christopher, Alyamani, Mohammad, Chung, Yoon-Mi, Wang, Chenyao, Patel, Mona, Rathi, Nityam, Zhu, Ziqi, Willard, Belinda, Stauffer, Shaun

Volltext